Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 3546 entries
View as:

SCOT Registry: Small Cell Lung Cancer Treatment and Outcome

Phase: N/A Priority: Normal
NCT ID: NCT00997061 Org: User:
Start: 11/30/09 End: 02/29/12 Due: 02/28/13

A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02014480 Org: User:
Start: 02/01/13 End: 06/11/13 Due: 06/11/14

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03294135 Org: User:
Start: 10/05/17 End: 10/25/21 Due: 10/25/22

A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study

Phase: N/A Priority: Normal
NCT ID: NCT03089879 Org: User:
Start: 03/16/17 End: 08/31/17 Due: 08/31/18

A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00058526 Org: User:
Start: 03/20/03 End: 09/06/06 Due: 09/06/07

Efficacy and Safety of Ambrisentan in Children 8-18yrs

Phase: N/A Priority: Normal
NCT ID: NCT01332331 Org: User:
Start: 01/04/11 End: 11/12/13 Due: 11/12/14

A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00642148 Org: User:
Start: 02/14/08 End: 07/27/09 Due: 07/27/10

Cervarix Long-term Safety Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01498627 Org: User:
Start: 08/31/08 End: 12/31/14 Due: 12/31/15

Perennial Allergic Rhinitis In Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00257595 Org: User:
Start: 08/31/05 End: - Due: -

Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00851344 Org: User:
Start: 09/30/08 End: 11/30/08 Due: 11/30/09

Effect of the GSK2245035 on the Allergen-induced Asthmatic Response

Phase: N/A Priority: Normal
NCT ID: NCT02833974 Org: User:
Start: 12/05/16 End: 05/04/18 Due: 05/04/19

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

Phase: N/A Priority: Normal
NCT ID: NCT00334607 Org: User:
Start: 06/30/06 End: 06/30/07 Due: 06/30/08

Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children

Phase: N/A Priority: Normal
NCT ID: NCT01027845 Org: User:
Start: 12/08/09 End: 09/17/11 Due: 09/17/12

ARI103094-Follow-Up Study for REDUCE Study Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00883909 Org: User:
Start: 04/09/09 End: 12/29/10 Due: 12/29/11

Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment

Phase: N/A Priority: Normal
NCT ID: NCT01386983 Org: User:
Start: 03/31/09 End: 06/30/10 Due: 06/30/11

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01725672 Org: User:
Start: 09/27/12 End: 08/21/13 Due: 08/21/14

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

Phase: N/A Priority: Normal
NCT ID: NCT00025727 Org: User:
Start: 05/31/01 End: - Due: -

Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00376714 Org: User:
Start: 08/16/06 End: 04/03/07 Due: 04/03/08

Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China

Phase: N/A Priority: Normal
NCT ID: NCT04853225 Org: User:
Start: 04/22/20 End: 06/25/24 Due: 06/25/25

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00426361 Org: User:
Start: 02/13/07 End: 07/25/08 Due: 07/25/09

Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00224471 Org: User:
Start: 12/31/03 End: 01/31/06 Due: 01/31/07

A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains

Phase: N/A Priority: Normal
NCT ID: NCT01416597 Org: User:
Start: 08/31/11 End: 12/31/11 Due: 12/31/12

Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.

Phase: N/A Priority: Normal
NCT ID: NCT00307008 Org: User:
Start: 10/31/03 End: 02/28/05 Due: 02/28/06

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections

Phase: N/A Priority: Normal
NCT ID: NCT01381562 Org: User:
Start: 10/03/11 End: 03/05/12 Due: 03/05/13

Bipolar Study in Adults at Least 18 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00067938 Org: User:
Start: 08/31/03 End: 08/31/04 Due: 08/31/05